West Pharmaceutical Services Inc
NYSE:WST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
West Pharmaceutical Services Inc
NYSE:WST
|
US |
|
Arvinas Inc
NASDAQ:ARVN
|
US |
Multiples-Based Value
The Multiples-Based Value of one
WST
stock under the Base Case scenario is
301.3
USD.
Compared to the current market price of 265.93 USD,
West Pharmaceutical Services Inc
is
Undervalued by 12%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
WST Competitors Multiples
West Pharmaceutical Services Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
19.1B USD | 6.2 | 38.8 | 23.2 | 29.5 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
956.9B USD | 335.1 | 3 967.4 | 1 136.9 | 2 189.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
189.4B USD | 4.3 | 28.3 | 19.6 | 26.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
138.7B USD | 5.6 | 38.4 | 19.5 | 28.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
309.5B CNY | 6.8 | 16.2 | 16.9 | 16.9 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.9B CHF | 5.3 | 36.5 | 27.2 | 27.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.1B USD | 4.7 | 25.6 | 18.8 | 22.3 | |
| US |
|
Waters Corp
NYSE:WAT
|
31.2B USD | 9.9 | 48.6 | 31.4 | 39.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.3B USD | 1.8 | 21.6 | 12 | 18 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 6.7 | 31 | 22.9 | 25.5 |